Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors

NCT07561437 is registered in ClinicalTrials.gov with Base Therapeutics (Shanghai) Co., Ltd. as lead sponsor.

NCT NCT07561437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07561437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors
Lead sponsor
Base Therapeutics (Shanghai) Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
March 9, 2026
Completion date
October 31, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors